Last month, OrganiGram expanded beyond its single facility in New Brunswick with the acquisition of The Edibles & Infusions Corporation, a maker of cannabis-infused products including soft-chew edibles. The acquisition gives OrganiGram a second operating facility and a footprint in Western Canada. That expansion would be timed well if the Canadian market growth accelerates, as the analyst predicts. But investors should focus more on the specific results as OrganiGram integrates the acquisition. Today's analyst call on Tilray isn't a good reason for OrganiGram shares to pop.